Posted in the last 24 hours

Fresh from the desks

Patient Care

The Sound in the ICU That Has No Column in the Chart

A physician's essay on grief and whale song points at something the medical record has never measured, that a family's wail carries real physiological information. Crying and whale calls have decades of published science behind them; the sound that fills an ICU when someone dies has no column in any chart.

By James T.·8 min read
Employee Benefits

The $5,250 Tuition Benefit Is a 1986 Number

Credit unions ranked among the best workplaces cap education benefits at $5,250, the largest amount the IRS lets an employer give tax-free. The figure was set in 1986 and never moved while tuition tripled and student debt topped $1.86 trillion, until an indexing fix finally arrives in 2027.

By Vasil V.·8 min read
Antitrust

The World's Biggest Generic Drugmaker Is Accused of the Branded Playbook

Turkish antitrust regulators are investigating Teva for patent-system manipulation and disparaging rivals, echoing a 2024 European Commission fine of 462.6 million euros for the same conduct around Copaxone. The accusation sits on the seam between the two companies Teva is: the generic challenger and the branded defender.

By Victoria C.·8 min read
Retirement Planning

The Retirement Advice That Benefits Your Heirs More Than You

The standard playbook for a retiree with more than they'll spend, drain the tax-deferred account first, save the Roth, let the brokerage pass with its stepped-up basis, minimizes the heir's tax bill. It does so partly at the cost of the retiree's own flexibility, and the payoff depends on a future nobody has seen.

By Vasil V.·8 min read
Rural Health

Medicaid Cuts Are Closing the Last Mile of Rural Care First

Federal Medicaid reductions are usually measured in coverage lost and dollars cut. In rural Maine, hospitals losing about 1 percent of revenue are dropping birthing units and leaning on a philanthropy-funded air ambulance service, turning a budget line into miles a family must drive at 2 a.m.

By James T.·8 min read
Biotech Economy

The Money Left Massachusetts Biotech Before the Jobs Did

Massachusetts biopharma employment fell for the first time in two decades in 2025, even as the same industry snapshot shows 2026 venture funding up 25 percent and $18 billion in acquisitions. Jobs are the slowest signal in the industry; capital is the fastest, and the two numbers are just describing different years.

By Vasil V.·8 min read
Cancer Screening

In Long-Term Care, the Screening Decision Is Made by Logistics

National cancer screening guidelines stop offering guidance for women past 75, exactly the age long-term care residents have often just entered. In the resulting silence, whether a resident gets screened is decided not by medicine but by who can arrange transportation to an off-site appointment.

By James T.·8 min read
Patient Safety

Hospital Diversion Software Is Only as Strong as Its Most Human Link

A California hospital's drug-diversion AI flagged a nurse stealing patients' pain medication for weeks before anyone acted. The software did its job; the failure was in the unfunded human review every diversion system quietly depends on to turn a flag into an intervention.

By James T.·8 min read
Economy

What Consumers Feel Is the Price Level, Not the Inflation Rate

Inflation is officially cooling to 3.4 percent, but consumer surveys show nearly 80 percent of households still cutting back and a third making extreme choices. The gap is not confusion, it is the difference between a flow the Fed can steer and a stock of accumulated prices that policy can never subtract from.

By Vasil V.·8 min read
B2B Research

Most Popular Research Articles

Intent Data

Intent Data Providers For B2B

Non-English intent signal is still under twenty percent of total volume industrywide, which means most platforms are seeing a fraction of the buying activity happening outside English language markets.

By Marko P.·8 min read
Knowledge Management

Knowledge Management Solutions

One vendor is explicitly competing on restraint, arguing that a plausible AI generated article that is subtly wrong is worse for a knowledge base than no article at all.

By Marko P.·8 min read
MDR

Managed Detection And Response Services

Forrester's own buyer guidance undercuts the AI pitch: providers are getting measurably more efficient, and there is little evidence yet that any of that efficiency is reaching customer pricing.

By Marko P.·8 min read
MDR Europe

Managed Detection And Response Services In Europe

Forrester's guidance to buyers is blunt: having a data centre in the EU answers one sovereignty question out of four, and most vendor pitches stop at the first.

By Marko P.·8 min read
Manufacturing Tech

Manufacturing Technology Services

Forrester frames 2026's binding constraint as a workforce that cannot be trained fast enough, which makes this a services category built around people more than platforms.

By Marko P.·8 min read
Market Intelligence

Market And Competitive Intelligence Platforms

Generative AI should have commoditized this category, and instead Forrester's criteria count kept climbing, because the moat was always licensed source access, not summarization.

By Marko P.·8 min read
Open Banking

Open Banking Intermediaries

Two of the category's most prominent independent players are now owned by the card networks they were supposed to route around.

By Marko P.·8 min read
Change Management

Organizational Change Management Services

Forrester's provider count nearly doubled in three years, and every other technology category in this series points at the same root cause: the software works and the organisation does not change.

By Marko P.·8 min read
PLM

Product Lifecycle Management Platforms For Discrete Manufacturers

Every reference customer for one vendor said they would buy again, which in PLM can mean genuine excellence or a customer base that has nowhere else to go once the evidence chain is built.

By Marko P.·8 min read
Announcements

News from Mavengity

Why Mavengity

Editorial standards you can check

Independently researched

We start from public rate filings, regulator guidance, and lender disclosures, not marketing copy.

Plain-English explanations

If a term needs a footnote, we explain it in the sentence instead of hiding it in the fine print.

Straight, not slanted

We flag trade-offs and blind spots, not just the upside, so you get the full picture before you decide.

Written for readers, not lenders

Mavengity is reader-supported and editorially independent from the products we cover.